SeaCrest Wealth Management LLC Has $596,000 Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

SeaCrest Wealth Management LLC grew its stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 21.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,904 shares of the biotechnology company’s stock after buying an additional 339 shares during the period. SeaCrest Wealth Management LLC’s holdings in Axon Enterprise were worth $596,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Brookstone Capital Management raised its stake in shares of Axon Enterprise by 5.1% in the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after purchasing an additional 41 shares in the last quarter. HB Wealth Management LLC raised its stake in shares of Axon Enterprise by 3.9% in the 4th quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock valued at $294,000 after buying an additional 43 shares in the last quarter. Envestnet Portfolio Solutions Inc. lifted its holdings in shares of Axon Enterprise by 1.1% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock worth $1,033,000 after acquiring an additional 43 shares during the period. UMB Bank n.a. boosted its position in shares of Axon Enterprise by 11.0% during the 4th quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock valued at $115,000 after acquiring an additional 44 shares in the last quarter. Finally, Rise Advisors LLC boosted its position in shares of Axon Enterprise by 49.0% during the 1st quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock valued at $45,000 after acquiring an additional 47 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Morgan Stanley upped their target price on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, April 26th. Argus assumed coverage on shares of Axon Enterprise in a research report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price objective for the company. Barclays upped their price target on Axon Enterprise from $308.00 to $381.00 and gave the company an “overweight” rating in a research note on Wednesday, May 8th. JPMorgan Chase & Co. increased their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. Finally, William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $335.27.

View Our Latest Stock Report on Axon Enterprise

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 43,668 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total value of $13,534,459.92. Following the completion of the transaction, the insider now directly owns 189,719 shares in the company, valued at $58,801,506.86. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Axon Enterprise news, insider Jeffrey C. Kunins sold 43,668 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total value of $13,534,459.92. Following the completion of the sale, the insider now owns 189,719 shares in the company, valued at $58,801,506.86. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Julie A. Cullivan sold 993 shares of the firm’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $281.72, for a total transaction of $279,747.96. Following the completion of the sale, the director now owns 4,553 shares of the company’s stock, valued at $1,282,671.16. The disclosure for this sale can be found here. Insiders have sold 89,447 shares of company stock valued at $27,684,677 in the last three months. 5.70% of the stock is currently owned by corporate insiders.

Axon Enterprise Trading Up 1.2 %

NASDAQ AXON opened at $296.56 on Thursday. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.55 and a current ratio of 2.91. The stock’s 50 day moving average price is $294.87 and its two-hundred day moving average price is $285.85. The stock has a market capitalization of $22.38 billion, a price-to-earnings ratio of 86.71 and a beta of 0.95.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. The business had revenue of $460.74 million for the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The firm’s revenue for the quarter was up 34.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.51 earnings per share. As a group, analysts anticipate that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.